Belgian Regulator Presses Roche Further Over Biosimilar Abuse Allegations

Competition Authority Escalates Rituximab And Trastuzumab Case

 
• By Dave Wallace
  
The Belgian Competition Authority is escalating a complaint against Roche (Shutterstock)

More from Legal & IP

More from Generics Bulletin